Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 132,805 | 100,781 | -32,024 | $7.04M | $29.70M | 17.28% | +$22.67M |
| Cidara Therapeutics Inc | 108,404 | 108,404 | 0 | $10.38M | $23.95M | 13.93% | +$13.56M |
| Protara Therapeutics, Inc.(TARA) | 2,139,000 | 2,834,652 | +695,652 | $9.30M | $15.11M | 8.79% | +$5.80M |
| Heron Therapeutics, Inc.(HRTX) | 8,753,290 | 8,753,290 | 0 | $11.03M | $11.38M | 6.62% | +$350.1K |
| MapLight Therapeutics, Inc.(MPLT) | 0 | 522,305 | +522,305 | $0 | $9.17M | 5.34% | +$9.17M |
| ABIVAX Société AnonymeADS(ABVX) | 64,389 | 67,000 | +2,611 | $5.47M | $9.04M | 5.26% | +$3.57M |
| Evommune, Inc.(EVMN) | 0 | 506,754 | +506,754 | $0 | $8.68M | 5.05% | +$8.68M |
| Mineralys Therapeutics, Inc.(MLYS) | 175,600 | 151,000 | -24,600 | $6.66M | $5.48M | 3.19% | -$1.18M |
| Lantheus Holdings, Inc.(LNTH) | 73,545 | 74,687 | +1,142 | $3.77M | $4.97M | 2.89% | +$1.20M |
| Jasper Therapeutics, Inc.(JSPR) | 2,668,395 | 2,668,395 | 0 | $6.21M | $4.88M | 2.84% | -$1.32M |
| Avalo Therapeutics, Inc.(AVTX) | 263,642 | 263,642 | 0 | $3.35M | $4.79M | 2.79% | +$1.44M |
| Esperion Therapeutics Inc Ne | 0 | 1,210,000 | +1,210,000 | $0 | $4.48M | 2.60% | +$4.48M |
| Verrica Pharmaceuticals Inc.(VRCA) | 0 | 471,559 | +471,559 | $0 | $3.92M | 2.28% | +$3.92M |
| InspireMD, Inc.(NSPR) | 2,143,698 | 2,143,698 | 0 | $5.17M | $3.82M | 2.22% | -$1.35M |
| Rapt Therapeutics Inc | 79,977 | 108,000 | +28,023 | $2.06M | $3.66M | 2.13% | +$1.60M |
| Sutro Biopharma, Inc.(STRO) | 0 | 312,000 | +312,000 | $0 | $3.61M | 2.10% | +$3.61M |
| Terns Pharmaceuticals Inc | 20,000 | 70,000 | +50,000 | $150.2K | $2.83M | 1.65% | +$2.68M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 130,000 | 130,000 | 0 | $2.00M | $2.73M | 1.59% | +$731.3K |
| Viridian Therapeutics, Inc.(VRDN) | 86,500 | 86,500 | 0 | $1.87M | $2.69M | 1.57% | +$825.2K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 352,000 | 352,000 | 0 | $2.08M | $2.66M | 1.55% | +$580.8K |
| Trevi Therapeutics, Inc.(TRVI) | 205,000 | 205,000 | 0 | $1.88M | $2.57M | 1.49% | +$690.9K |
| Profound Medical Corp.(PROF) | 0 | 285,710 | +285,710 | $0 | $2.25M | 1.31% | +$2.25M |
| Kazia Therapeutics LimitedADS(KZIA) | 0 | 300,000 | +300,000 | $0 | $2.07M | 1.20% | +$2.07M |
| Rezolute, Inc.(RZLT) | 750,000 | 750,000 | 0 | $7.05M | $1.77M | 1.03% | -$5.28M |
| Tenax Therapeutics, Inc.(TENX) | 83,333 | 83,333 | 0 | $634.2K | $1.02M | 0.59% | +$381.7K |
| Edesa Biotech, Inc.(EDSA) | 687,500 | 687,500 | 0 | $1.70M | $976.3K | 0.57% | -$721.9K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 6,500 | 6,500 | 0 | $224.2K | $431.5K | 0.25% | +$207.3K |
| Ventyx Biosciences Inc | 40,000 | 40,000 | 0 | $124.4K | $361.2K | 0.21% | +$236.8K |
| CytomX Therapeutics, Inc.(CTMX) | 80,000 | 80,000 | 0 | $255.2K | $340.8K | 0.20% | +$85.6K |
| Protagonist Therapeutics Inc | 3,700 | 3,700 | 0 | $245.8K | $323.2K | 0.19% | +$77.4K |
| Nurix Therapeutics, Inc.(NRIX) | 16,000 | 16,000 | 0 | $147.8K | $303.5K | 0.18% | +$155.7K |
| Ovid Therapeutics Inc.(OVID) | 160,000 | 160,000 | 0 | $208.0K | $260.8K | 0.15% | +$52.8K |
| Gossamer Bio, Inc.(GOSS) | 70,000 | 70,000 | 0 | $184.1K | $217.0K | 0.13% | +$32.9K |
| Immunome, Inc.(IMNM) | 10,000 | 10,000 | 0 | $117.1K | $214.8K | 0.12% | +$97.7K |
| Design Therapeutics, Inc.(DSGN) | 20,000 | 20,000 | 0 | $150.6K | $187.6K | 0.11% | +$37.0K |
| Immix Biopharma, Inc.(IMMX) | 35,000 | 35,000 | 0 | $73.2K | $183.1K | 0.11% | +$109.9K |
| Context Therapeutics Inc.(CNTX) | 100,000 | 100,000 | 0 | $96.9K | $147.0K | 0.09% | +$50.1K |
| Replimune Group, Inc.(REPL) | 20,000 | 15,000 | -5,000 | $83.8K | $145.8K | 0.08% | +$62.0K |
| Larimar Therapeutics, Inc.(LRMR) | 33,000 | 33,000 | 0 | $106.6K | $125.7K | 0.07% | +$19.1K |
| Xilio Therapeutics, Inc.(XLO) | 0 | 170,000 | +170,000 | $0 | $108.8K | 0.06% | +$108.8K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 61,000 | 13,000 | -48,000 | $771.6K | $105.8K | 0.06% | -$665.8K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 45,000 | 45,000 | 0 | $95.8K | $90.9K | 0.05% | -$5.0K |
| Precision BioSciences, Inc.(DTIL) | 20,000 | 20,000 | 0 | $110.4K | $83.2K | 0.05% | -$27.2K |
| Pyxis Oncology, Inc.(PYXS) | 55,000 | 40,000 | -15,000 | $122.1K | $46.0K | 0.03% | -$76.1K |
| PMV Pharmaceuticals, Inc.(PMVP) | 35,000 | 35,000 | 0 | $49.0K | $43.8K | 0.03% | -$5.3K |
| Aclaris Therapeutics, Inc.(ACRS) | 32,700 | 0 | -32,700 | $62.1K | $0 | — | -$62.1K |
| Alector Inc | 55,000 | 0 | -55,000 | $162.8K | $0 | — | -$162.8K |
| Alumis Inc | 946,683 | 0 | -946,683 | $3.78M | $0 | — | -$3.78M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 346,973 | 0 | -346,973 | $898.7K | $0 | — | -$898.7K |
| Erasca, Inc.(ERAS) | 65,000 | 0 | -65,000 | $141.7K | $0 | — | -$141.7K |
| Geron Corporation(GERN) | 80,000 | 0 | -80,000 | $109.6K | $0 | — | -$109.6K |
| Sutro Biopharma, Inc.(STRO) | 3,120,000 | 0 | -3,120,000 | $2.71M | $0 | — | -$2.71M |
| TELA Bio, Inc.(TELA) | 747,410 | 0 | -747,410 | $1.11M | $0 | — | -$1.11M |
| Tourmaline Bio Inc | 5,800 | 0 | -5,800 | $277.4K | $0 | — | -$277.4K |
| uniQure N.V.SHS(QURE) | 32,000 | 0 | -32,000 | $1.87M | $0 | — | -$1.87M |
| Wave Life Sciences, Inc.SHS(WVE) | 15,000 | 0 | -15,000 | $109.8K | $0 | — | -$109.8K |
| Zooz Pwr LtdSHARE SHARE | 2,000,000 | 0 | -2,000,000 | $4.28M | $0 | — | -$4.28M |